Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 59351-59400 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT06207812
Long-term Outcomes Associated With Juvenile-onset Mycosis Fungoides and Lymphomatoid Papulosis
N/A
Recruiting
100 participants
Started: Jan 19, 2024 · Completed: Jan 12, 2026
2 conditions
1 sponsor
1 location
NCT06321861
Motivational, Affective and Performance Effects of Caffeine Supplementation
NA
Recruiting
40 participants
Started: Jan 19, 2024 · Completed: May 1, 2024
3 conditions
3 sponsors
1 location
NCT06229067
Efficacy and Safety of PD-L1 Monoclonal Antibody Combined With Metronomic VEX in Advanced Triple-negative Breast Cancer
PHASE2
Not yet recruiting
182 participants
Started: Jan 19, 2024 · Completed: Jan 19, 2027
2 conditions
1 sponsor
0 locations
NCT06505512
A Study of Enterorenal Syndrome Assessed by Gastrointestinal Ultrasound Combined with Renal Artery Resistance Index
N/A
Recruiting
74 participants
Started: Jan 19, 2024 · Completed: Mar 31, 2025
2 conditions
1 sponsor
1 location
NCT06173037
RC88 in Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer
PHASE2
Recruiting
88 participants
Started: Jan 19, 2024 · Completed: Dec 31, 2026
3 conditions
1 sponsor
30 locations
NCT06494228
Comparison of Diagnostic Performances of 3D FLAIR, DIR and PSIR Sequences in Optic Neuritis
N/A
Recruiting
60 participants
Started: Jan 19, 2024 · Completed: Jan 19, 2025
2 conditions
1 sponsor
1 location
NCT05916417
TMS-fNIRS Personalized Dosing
NA
Recruiting
60 participants
Started: Jan 19, 2024 · Completed: Sep 30, 2026
2 conditions
1 sponsor
1 location
NCT06031584
A Study of BL-M07D1 in Patients With a Variety of Solid Tumors Including Locally Advanced or Metastatic HER2-positive/Low-expressing Urinary and Gastrointestinal Tumors
PHASE1/PHASE2
Recruiting
42 participants
Started: Jan 19, 2024 · Completed: Mar 31, 2026
1 condition
1 sponsor
1 location
NCT06053281
The Role of Vitamin D in Neuroinflammatory on Drug Resistant Epilepsy
EARLY_PHASE1
Recruiting
70 participants
Started: Jan 19, 2024 · Completed: Jul 1, 2025
1 condition
1 sponsor
1 location
NCT06127459
Virtual Reality in Rehabilitation of Executive Functions in Children With Mild or Moderate Traumatic Brain Injury
NA
Recruiting
44 participants
Started: Jan 19, 2024 · Completed: Dec 31, 2026
1 condition
5 sponsors
1 location
NCT06515899
Association of Middle Molecules Clearance With HDF Volume
N/A
Recruiting
400 participants
Started: Jan 19, 2024 · Completed: Jul 31, 2025
1 condition
1 sponsor
1 location
NCT05822362
CBD for Individuals at Risk for Alzheimer's Disease
PHASE2
Recruiting
236 participants
Started: Jan 19, 2024 · Completed: Apr 30, 2029
1 condition
1 sponsor
1 location
NCT05947136
PASCA-MM Study. Impact of the PASCA (PArcours de Santé au Cours du CAncer) Program on Complications Associated With Multiple Myeloma and/or Its Treatments in the Context of a First Hematopoietic Stem Cell Autograft, in Adults Aged 18 to 70.
NA
Recruiting
204 participants
Started: Jan 19, 2024 · Completed: Sep 14, 2027
2 conditions
2 sponsors
1 location
NCT06171750
Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors
PHASE1
Recruiting
97 participants
Started: Jan 19, 2024 · Completed: Jun 30, 2027
9 conditions
1 sponsor
5 locations
NCT06156865
Using Neuroimaging and Behavioral Assessments to Understand Late Talking
NA
Recruiting
45 participants
Started: Jan 19, 2024 · Completed: Jun 30, 2025
3 conditions
5 sponsors
2 locations
NCT06889948
The Effect of Daratumumab in Patients with Monoclonal Gammopathy of Renal Significance (MGRS) in Finland
PHASE2
Recruiting
30 participants
Started: Jan 19, 2024 · Completed: Jun 30, 2027
3 conditions
2 sponsors
1 location
NCT06249919
A Phase 1b/2a, Study Evaluating the Safety, PK/PD and Efficacy of NS101 in Healthy Volunteers and SSNHL Patients
PHASE1/PHASE2
Recruiting
138 participants
Started: Jan 19, 2024 · Completed: Jan 31, 2027
2 conditions
4 sponsors
16 locations
NCT05840159
A Study of Doxycycline to Treat Chlamydial Infection
PHASE4
Recruiting
664 participants
Started: Jan 19, 2024 · Completed: Feb 28, 2026
1 condition
1 sponsor
7 locations
NCT06007261
Validation of Rapid On-site Diagnostics in Early Stage Lung Cancer Sampling With a Higher Harmonic Generation Microscope
N/A
Recruiting
250 participants
Started: Jan 19, 2024 · Completed: Apr 30, 2027
1 condition
4 sponsors
1 location
NCT06231680
Thalidomide Prevention or Treatment of Camrelizumab-induced Reactive Cutaneous Capillary Endothelial Proliferation (RCCEP)
PHASE2
Recruiting
132 participants
Started: Jan 19, 2024 · Completed: Sep 30, 2025
2 conditions
2 sponsors
2 locations
NCT06564571
Artificial Intelligence in Endoscopic Ultrasound
N/A
Recruiting
310 participants
Started: Jan 19, 2024 · Completed: Dec 31, 2027
3 conditions
1 sponsor
1 location
NCT05959018
Efficacy & Cost Effectiveness of Antimicrobial-impregnated CVCs in CLABSI Prevention in a Malaysia Adult ICU
NA
Recruiting
110 participants
Started: Jan 19, 2024 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT06367634
TEOSYAL® PureSense ULTRA DEEP Versus Restylane® Lidocaine for the Correction of Moderate to Severe Nasolabial Folds in Chinese Adults
NA
Recruiting
390 participants
Started: Jan 19, 2024 · Completed: Feb 28, 2026
1 condition
1 sponsor
1 location
NCT06230679
Effectiveness of NESA in the Treatment of Cancer Survivors
NA
Recruiting
40 participants
Started: Jan 19, 2024 · Completed: Dec 19, 2025
1 condition
1 sponsor
1 location
NCT06071078
Impact of a Protocol for Announcing Decision of Withholding and Withdrawing Life-sustaining Treatments on the Stress of the Relatives in the Emergency Departments
NA
Recruiting
538 participants
Started: Jan 19, 2024 · Completed: Jan 19, 2026
1 condition
1 sponsor
9 locations
NCT05625555
Predictors of Intravenous Ketamine Response in TRD
PHASE3
Recruiting
40 participants
Started: Jan 19, 2024 · Completed: Feb 28, 2025
3 conditions
2 sponsors
1 location
NCT06260163
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis
PHASE3
Recruiting
120 participants
Started: Jan 19, 2024 · Completed: Aug 14, 2028
1 condition
1 sponsor
61 locations
NCT06055452
Effects of SGLT2 Inhibitors in Pre-heart Failure Populations With Hypertension
PHASE4
Recruiting
120 participants
Started: Jan 19, 2024 · Completed: Dec 31, 2024
2 conditions
1 sponsor
2 locations
NCT06065436
Concurrent Low Intensity Shockwave Therapy on Collagenase Clostridium Histolyticum for Peyronie's Disease
NA
Recruiting
60 participants
Started: Jan 19, 2024 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT06033131
PI4 - A Trial Assessing Metformin to Prolong Gestation in Preterm Preeclampsia
PHASE3
Recruiting
294 participants
Started: Jan 19, 2024 · Completed: Jul 31, 2029
1 condition
2 sponsors
9 locations
NCT06235450
A Usability Study of iTEAR100 For Combined EyeLid Microblepharoexfoliation and Neurostimulation
PHASE1
Recruiting
200 participants
Started: Jan 19, 2024 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT06163326
A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental Vitiligo
PHASE3
Recruiting
400 participants
Started: Jan 19, 2024 · Completed: Apr 23, 2027
1 condition
1 sponsor
74 locations
NCT06120075
A Study of AB801 Monotherapy and Combination Therapy in Participants With Advanced Malignancies
PHASE1
Recruiting
91 participants
Started: Jan 19, 2024 · Completed: Nov 30, 2026
1 condition
1 sponsor
10 locations
NCT06523283
"The Effect of Nature Images Accompanied by Music on Breastfeeding, Breastfeeding Satisfaction and Maternal Attachment"
NA
Recruiting
90 participants
Started: Jan 18, 2024 · Completed: Aug 10, 2024
1 condition
1 sponsor
1 location
NCT06253728
A Study of Biochemical Response to Alternative Proteins
NA
Recruiting
24 participants
Started: Jan 18, 2024 · Completed: Dec 31, 2025
3 conditions
1 sponsor
1 location
NCT06278909
Trigeminal Nerve Stimulation in Treatment-resistant Generalized Anxiety Disorder: a Feasibility Study
NA
Recruiting
10 participants
Started: Jan 18, 2024 · Completed: Apr 1, 2026
1 condition
1 sponsor
1 location
NCT06310148
Evaluation of the Chronic Disease Co-Care Pilot Scheme
NA
Recruiting
3,772 participants
Started: Jan 18, 2024 · Completed: Dec 31, 2026
5 conditions
3 sponsors
1 location
NCT06533917
Spinal Cord Stimulation for Chronic Abdominal Pain Patients
NA
Recruiting
10 participants
Started: Jan 18, 2024 · Completed: Jun 4, 2025
1 condition
1 sponsor
1 location
NCT05667987
Evaluation of the Benefit of Lidocaine on the Prevention of the Risk of Post Endoscopic Retrograde Cholangio-pancreatography Pancreatitis.
NA
Recruiting
1,800 participants
Started: Jan 18, 2024 · Completed: Apr 1, 2026
1 condition
1 sponsor
1 location
NCT06110078
Carbonic Anhydrase Inhibitors and Carbonation: A Novel Approach to Reduce Soda Consumption
EARLY_PHASE1
Enrolling by invitation
44 participants
Started: Jan 18, 2024 · Completed: May 1, 2024
1 condition
1 sponsor
1 location
NCT06212869
Green Light and Transcranial Direct Current Stimulation in Migraine Patients
NA
Recruiting
45 participants
Started: Jan 18, 2024 · Completed: Oct 31, 2024
1 condition
1 sponsor
1 location
NCT06326944
Fascia Transversalis Versus Transversus Abdominis Plane Block for Children Undergoing Inguinal Hernia Surgery
PHASE2
Recruiting
50 participants
Started: Jan 18, 2024 · Completed: May 31, 2024
1 condition
1 sponsor
1 location
NCT05405868
Nicotinamide in Glaucoma (NAMinG): A Randomised, Placebo-controlled, Multi-centre, Phase III Trial
PHASE3
Recruiting
496 participants
Started: Jan 18, 2024 · Completed: Jun 30, 2027
1 condition
2 sponsors
10 locations
NCT06001255
ARTEMIS-003: HS-20093 in Patients With Metastatic Castrate-resistant Prostate Cancer (mCRPC) and Advanced Solid Tumors
PHASE2
Recruiting
120 participants
Started: Jan 18, 2024 · Completed: Dec 31, 2025
1 condition
1 sponsor
15 locations
NCT05905146
Impact of a Personalized Medication Plan on Duration of Treatment With Potent Opioids in Acute Non-cancer Musculoskeletal Pain.
NA
Recruiting
200 participants
Started: Jan 18, 2024 · Completed: Jul 18, 2026
1 condition
1 sponsor
3 locations
NCT06345365
MA+AZA Regimen for the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)
PHASE3
Recruiting
154 participants
Started: Jan 18, 2024 · Completed: Dec 31, 2028
1 condition
10 sponsors
11 locations
NCT05985954
Open-label Phase 1b Study of Ulixertinib and Cetuximab or Ulixertinib in Combination With Cetuximab and Encorafenib in Patients With Unresectable or Metastatic Colorectal Cancer Who Have Previously Received EGFR or BRAF-directed Therapy
PHASE1
Recruiting
27 participants
Started: Jan 18, 2024 · Completed: Mar 28, 2028
1 condition
3 sponsors
1 location
NCT06224348
A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis on Background Topical Corticosteroids
PHASE3
Active, not recruiting
643 participants
Started: Jan 18, 2024 · Completed: Dec 11, 2025
1 condition
1 sponsor
167 locations
NCT05869591
DOAC in Patients with Child a or B Liver Cirrhosis
PHASE2
Recruiting
40 participants
Started: Jan 18, 2024 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT06235281
Phototherapy and Mogamulizumab in Early Stage MF (PLIGHT)
EARLY_PHASE1
Recruiting
20 participants
Started: Jan 18, 2024 · Completed: Sep 1, 2029
1 condition
2 sponsors
1 location
Previous
1
More pages
1185
1186
1187
1188
1189
1190
1191
More pages
2369
Next